ARCHIVES

GSK’s Pazopanib Benefits Similar to Sunitinib; Sponsor Points to More Favorable Safety Profile

This article is from The Cancer Letter archive.

Vol. 36 No. 8 | August 30, 2013

Download PDF Visit The Full Archive

Related Articles

Phase IIb Trial of CRLX101 Fails Overall Survival Endpoint

March 29, 2013

ACS Clinical Awards Available For 1996

March 31, 1995

New Treatment For CML Could Be Model for Molecular Target-Based Therapeutics

December 10, 1999

As Zeneca Buys Salick, Implications For Oncology Managed Care Uncertain

April 4, 1997

FDA Commissioner Holds Up IND While Reviewing Toxicology Guidelines

August 14, 1981

Vanderbilt physician-scientist Philip Browning, 51, dead of colon cancer.

June 25, 2004